Strober, B., Paul, C., Blauvelt, A., Thaçi, D., Puig Sanz, L., Lebwohl, M., . . . Eyerich, K. (2023). Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis.
Citación estilo ChicagoStrober, B.|||0000-0002-8394-2057, et al. Bimekizumab Efficacy and Safety in Patients With Moderate to Severe Plaque Psoriasis. 2023.
Cita MLAStrober, B.|||0000-0002-8394-2057, et al. Bimekizumab Efficacy and Safety in Patients With Moderate to Severe Plaque Psoriasis. 2023.
Precaución: Estas citas no son 100% exactas.